Related Experiment Video
Updated: Sep 2, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Sex Differences in the Impact of Aortic Valve Calcium Score on Mortality After Transcatheter Aortic Valve Replacement
Parth P Patel1, Abdallah El Sabbagh2, Patrick W Johnson3
1Mayo Clinic Alix School of Medicine, Jacksonville, FL (P.P.P.).
Insights
Aortic valve calcium score (AVCS) predicts mortality after transcatheter aortic valve replacement (TAVR). Higher AVCS increases mortality risk in women, but not men, after TAVR.
Area of Science:
- Cardiology
- Interventional Cardiology
- Geriatric Medicine
Background:
- Transcatheter aortic valve replacement (TAVR) is a standard treatment for severe aortic stenosis.
- Identifying predictors of mortality post-TAVR is crucial for patient management.
- Aortic valve calcium score (AVCS) is a potential risk stratification tool.
Purpose of the Study:
- To investigate the association between aortic valve calcium score (AVCS) and long-term mortality after TAVR.
- To evaluate potential sex differences in this association.
Main Methods:
- Retrospective analysis of 2543 patients undergoing TAVR from 2010-2021.
- Aortic valve calcium score (AVCS) derived from preoperative CT scans.
- Kaplan-Meier curves and Cox regression models used for mortality analysis.
Main Results:
- Higher AVCS was associated with increased mortality risk post-TAVR (P<0.001).
- A sex difference was observed: each 500-unit AVCS increase correlated with a 7% mortality risk increase in women (aHR, 1.07 [95% CI, 1.02-1.12]), but not men.
Conclusions:
- A significant sex difference exists in the relationship between AVCS and long-term mortality following TAVR.
- AVCS may enhance preprocedural risk stratification for women undergoing TAVR.
- Further research is warranted to confirm these findings.
Background:
Transcatheter aortic valve replacement (TAVR) is now an approved alternative to surgical aortic valve replacement for the treatment of severe aortic stenosis. As the clinical adoption of TAVR expands, it remains important to identify predictors of mortality after TAVR. We aimed to evaluate the impact of sex differences in aortic valve calcium score (AVCS) on long-term mortality following TAVR in a large patient sample.
Methods:
We included consecutive patients who successfully underwent TAVR for treatment of severe native aortic valve stenosis from June 2010 to May 2021 across all US Mayo Clinic sites with follow-up through July 2021. AVCS values were obtained from preoperative computed tomography of the chest. Additional clinical data were abstracted from medical records. Kaplan-Meier curves and Cox-proportional hazard regression models were employed to evaluate the effect of AVCS on long-term mortality.
Results:
A total of 2543 patients were evaluated in the final analysis. Forty-one percent were women, median age was 82 years (Q1: 76, Q3: 86), 18.4% received a permanent pacemaker following TAVR, and 88.5% received a balloon expandable valve. We demonstrate an increase in mortality risk with higher AVCS after multivariable adjustment (P<0.001). When stratified by sex, every 500-unit increase in AVCS was associated with a 7% increase in mortality risk among women (adjusted hazard ratio, 1.07 [95% CI, 1.02-1.12]) but not in men.
Conclusions:
We demonstrate a notable sex difference in the association between AVCS and long-term mortality in a large TAVR patient sample. This study highlights the potential value of AVCS in preprocedural risk stratification, specifically among women undergoing TAVR. Additional studies are needed to validate this finding.
More Related Videos
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management